Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

8.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Alginate Hydrogel-Lipid Nanodispersion Bio-Mask: A Preliminary Study of Skin Hydration, Barrier Function, and Regenerative Potential.

Materials (Basel, Switzerland)·2026
Same author

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose-driven glioblastoma.

Molecular oncology·2026
Same author

Corrigendum to "Chemical modification of STL427944 toward morpholine-based 1,3,5-triazines as anticancer agents targeting FOXM1: green synthesis, biological evaluation and ADME-Tox profiling in a colorectal cancer model" [304, 15 February 2026, 118532].

European journal of medicinal chemistry·2026
Same author

Release of secondary microplastics and additives from polymer pellets exposed to artificial sunlight and aquatic environment.

Journal of hazardous materials·2026
Same author

Synthesis and biological evaluation of 1,3,5-triazine and 2-aminopyrimidine scaffolds as chemical probes targeting the 5-HT<sub>7</sub>-FOXM1 axis in triple-negative breast cancer.

European journal of medicinal chemistry·2026
Same author

Spectroscopic and Theoretical Analysis of <i>N</i>-Ethylphenothiazine Derivatives: Alkyl Chain Length Effects on Solvatochromism, Fluorescence Efficiency, and Excited-State Polarity.

The journal of physical chemistry. B·2026

Related Experiment Video

Updated: Mar 25, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.5K

Small molecule glycoconjugates with anticancer activity.

Gabriela Pastuch-Gawołek1, Katarzyna Malarz2, Anna Mrozek-Wilczkiewicz3

  • 1Silesian University of Technology, Faculty of Chemistry, Chair of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Krzywoustego 4, 44-100 Gliwice, Poland.

European Journal of Medicinal Chemistry
|February 19, 2016
PubMed
Summary

New glycoconjugates derived from quinolines show promising anticancer activity. These compounds, especially when combined with copper ions, effectively target cancer cells by generating reactive oxygen species and intercalating DNA.

Keywords:
AnticancerChelatorsGlycoconjugatesQuinolineReactive oxygen species

More Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

4.1K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

8.1K

Related Experiment Videos

Last Updated: Mar 25, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.5K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

4.1K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

8.1K

Area of Science:

  • Medicinal Chemistry
  • Organic Chemistry
  • Cancer Biology

Background:

  • Glycoconjugates, combinations of sugars with organic molecules, possess inherent biological properties suitable for drug development.
  • Quinolines are a class of organic compounds with diverse biological activities.
  • Developing novel anticancer agents remains a critical area of pharmaceutical research.

Purpose of the Study:

  • To design and synthesize novel glycoconjugates by linking quinoline scaffolds with carbohydrate moieties.
  • To evaluate the cytotoxic activity of these synthesized glycoconjugates against cancer cell lines.
  • To investigate the potential synergistic effects of copper ions in enhancing the anticancer efficacy of these compounds.

Main Methods:

  • Synthesis of glycoconjugates using small molecular quinolines and substituted gluco- and galactopyranosyl amines.
  • In vitro cytotoxicity assays to determine the efficacy of compounds against various cancer cell lines at the micromolar level.
  • Assessment of the impact of copper ion complexation on the cytotoxic activity of the glycoconjugates.
  • Mechanistic studies to elucidate the mode of action, including reactive oxygen species generation and DNA intercalation.

Main Results:

  • Synthesized glycoconjugates demonstrated significant cytotoxic effects against cancer cells at micromolar concentrations.
  • The parent quinoline compounds exhibited minimal activity at comparable concentrations.
  • Co-administration with copper ions markedly enhanced the anticancer potency of the designed glycoconjugates.
  • Mechanism of action involves the induction of reactive oxygen species and DNA intercalation, leading to cancer cell death.

Conclusions:

  • The synthesized quinoline-based glycoconjugates represent a promising new class of anticancer agents.
  • Copper ion complexation is a viable strategy to potentiate the therapeutic efficacy of these novel compounds.
  • The observed mechanism of action provides a foundation for further preclinical development of these glycoconjugates for cancer therapy.